The Bulletin
Men's Weekly


.

SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia

  • Written by PR Newswire
SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia
  • This approval paves the way for exports to the world's fourth most populous country.
  • SK bioscience aims to continue to grow as a global vaccine brand beyond Korea by leveraging the advantages of cell-cultured vaccines.

SEONGNAM, South Korea, Oct. 23, 2024 /PRNewswire/ -- SK bioscience, a global innovative vaccine and biotech company committed to...